Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 116
Filter
1.
Chaos ; 34(4)2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38619247

ABSTRACT

In this work, we investigate the multifractal properties of eye movement dynamics of children with infantile nystagmus, particularly the fluctuations of its velocity. The eye movements of three children and one adult with infantile nystagmus were evaluated in a simple task in comparison with 28 children with no ocular pathologies. Four indices emerge from the analysis: the classical Hurst exponent, the singularity strength corresponding to the maximum of the singularity spectrum, the asymmetry of the singularity spectrum, and the multifractal strength, each of which characterizes a particular aspect of eye movement dynamics. Our findings indicate that, when compared to children with no ocular pathologies, patients with infantile nystagmus present lower values of all indices. Except for the multifractal strength, the difference in the remaining indices is statistically significant. To test whether the characterization of patients with infantile nystagmus in terms of multifractality indices allows them to be distinguished from children without ocular pathologies, we performed an unsupervised clustering analysis and classified the subjects using supervised clustering techniques. The results indicate that these indices do, indeed, distinctively characterize the eye movements of patients with infantile nystagmus.


Subject(s)
Eye Movements , Adult , Child , Humans , Cluster Analysis
2.
Rev Esp Quimioter ; 36(5): 498-506, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37476842

ABSTRACT

OBJECTIVE: The aim of this work was to estimate the conditioned probability for the diagnosis of SARS-CoV-2 infection with reverse transcription polymerase chain reaction (RT-PCR), viral antigen rapid diagnostic tests (Ag-RDT), and antibody detection tests depending on the prevalence in the specific healthcare settings in Spain in 2020, and on the pre-test probability (PTP) according to the clinical situation, age and unknown or close contacts of the patient. METHODS: Performance parameters of tests were obtained from literature. Prevalence data and PTP were obtained from Spanish sources and a survey, respectively. The post-test probability is the positive predictive value (PPV) when test is positive. For negative result, we also calculated the probability of having the infection (false negatives). RESULTS: For both RT-PCR and viral Ag-RDT, the lowest PPV values were for the population screenings. This strategy proved to be useful in ruling out infection but generates a high number of false positives. At individual level, both tools provided high PPV (≥ 97%) when the PTP values are over 35%. In seroprevalence studies, though the specificity of IgG alone tests is high, under low seroprevalence, false positives cannot be avoided. Total antibodies tests are useful for diagnosis of COVID-19 in those doubtful cases with RT-PCR or Ag-RDT tests being repeatedly negative. CONCLUSIONS: The interpretating of results depends not only on the accuracy of the test, but also on the prevalence of the infection in different settings, and the PTP associated to the patient before performing the test.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , COVID-19/diagnosis , Prevalence , Spain/epidemiology , Seroepidemiologic Studies , Sensitivity and Specificity , Probability , COVID-19 Testing
3.
Pediatr. aten. prim ; 24(93)ene. - mar. 2022. ilus, tab, graf
Article in Spanish | IBECS | ID: ibc-210336

ABSTRACT

Introducción: la detección precoz de alteraciones visuales en la infancia tiene importancia ya que pueden causar problemas en el desarrollo visual, el rendimiento escolar o, incluso, suponer un riesgo vital como el retinoblastoma. El objetivo de este estudio es realizar una revisión bibliográfica sobre las actividades diagnósticas que puede realizar el pediatra de Atención Primaria (PAP) para mejorar el cribaje de la ambliopía, e identificar la edad más adecuada para este cribado. Material y métodos: se ha realizado una búsqueda bibliográfica de textos científicos en inglés y español publicados en los últimos 20 años en bases de datos como PubMed y Google Académico. Algunas de las palabras clave fueron: “amblyopia”, “vision screening”, “pediatric”, “retinoscopy” y “photoscreener”. Resultados: se encontraron 376 resultados, seleccionándose 29 artículos y dos libros que incluían métodos diagnósticos de ambliopía realizados por el PAP (Bruckner, Hirschberg, Cover test, estereopsis y agudeza visual) y otros más avanzados (retinoscopia, autorrefractómetros, fotorrefractómetros y potenciales evocados). Los programas de cribado y derivación al oftalmólogo realizados por el PAP están basados en métodos tradicionales, siendo en general poco objetivos y heterogéneos. Conclusiones: los resultados encontrados no definen la edad óptima para el cribado, ni la prueba o combinación de pruebas más adecuadas para evitar derivaciones innecesarias o que una alteración pase inadvertida. Sin embargo, este cribado puede realizarse sencilla y rápidamente a partir de los 6 meses de vida mediante métodos avanzados como fotorrefractometría. Aumentar los recursos disponibles del PAP y conocer su aplicabilidad real y sus beneficios clínicos puede precisar posteriores investigaciones (AU)


Introduction: early detection of visual alterations in childhood has special relevance since it can cause problems in visual development, school performance, or even pose a vital risk such as retinoblastoma. The aim of this study was to conduct a traditional review about the diagnostic procedures that can be performed by the Primary Care Pediatrician (PCP) to improve the screening of amblyopia and to identify the most appropriate age for this screening.Material and methods: a bibliographic search of scientific texts in English and Spanish published in the last 20 years in databases such as PubMed and Google Scholar has been carried out. Some of the key words were: “amblyopia”, “vision screening”, “pediatric”, “retinoscopy” and “photoscreener”.Results: 376 results were found. 29 articles and 2 books were selected covering diagnostic methods of amblyopia performed by the PCP (Bruckner, Hirschberg, Cover test, stereopsis and visual acuity assessment) and others more advanced (retinoscopy, autorefractometry, photorefractometry and evoked potentials). The screening and ophthalmologist referral programs performed by the PCP are based on traditional methods and are generally not very objective and heterogeneous.Conclusions: the evidence does not allow to define the optimal age to amblyopia screening or which test or combination of tests could be the most appropriate to avoid unnecessary referrals or unnoticed alterations. However, this screening can be performed easily and quickly from the age of 6 months using diagnostic methods such as photorefractometry. Increasing the available resources in PCP clinic and knowing its applicability and clinical benefits may require further research. (AU)


Subject(s)
Humans , Primary Health Care , Amblyopia/diagnosis , Early Diagnosis , Visual Acuity
6.
Radiat Prot Dosimetry ; 164(1-2): 42-5, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25205835

ABSTRACT

Creating a sustainable network in biological and retrospective dosimetry that involves a large number of experienced laboratories throughout the European Union (EU) will significantly improve the accident and emergency response capabilities in case of a large-scale radiological emergency. A well-organised cooperative action involving EU laboratories will offer the best chance for fast and trustworthy dose assessments that are urgently needed in an emergency situation. To this end, the EC supports the establishment of a European network in biological dosimetry (RENEB). The RENEB project started in January 2012 involving cooperation of 23 organisations from 16 European countries. The purpose of RENEB is to increase the biodosimetry capacities in case of large-scale radiological emergency scenarios. The progress of the project since its inception is presented, comprising the consolidation process of the network with its operational platform, intercomparison exercises, training activities, proceedings in quality assurance and horizon scanning for new methods and partners. Additionally, the benefit of the network for the radiation research community as a whole is addressed.


Subject(s)
Biological Assay/methods , Disaster Planning/organization & administration , Radiation Injuries/prevention & control , Radiation Monitoring/methods , Radiation Protection/methods , Radioactive Hazard Release/prevention & control , Emergencies , Europe , Humans , Radiation Exposure/prevention & control , Safety Management/organization & administration
7.
Clin. transl. oncol. (Print) ; 16(6): 573-580, jun. 2014. tab, ilus
Article in English | IBECS | ID: ibc-127902

ABSTRACT

BACKGROUND AND PURPOSE: Anastomotic recurrence after radical sphincter-preserving surgery preceded by neoadjuvant therapy in locally advanced rectal cancer is an uncommon event that merits further assessment. The aim of this study is to analyze the effect of preoperative chemoradiation on the risk of anastomotic recurrence. Based on the initial extension of the tumor, we analyzed whether the distal surgical section was calculated through the virtual initial extension of the rectal tumor. PATIENTS AND METHODS: Eligible patients with locally advanced rectal cancer were offered preoperative chemoradiation, sphincter sparing surgery and intraoperative radiation therapy boost. RESULTS: 180 patients were treated with anterior resection (40 %), low anterior resection (45.6 %) and ultra-low anterior resection (14.4 %). With a median follow-up of 41.1 months (0.36-143 months), anastomotic recurrence was diagnosed in 9 patients (5 %). There was no statistical correlation with downstaging (T or N), downsizing effects, or with distance from the lower limit of the residual lesion to the distal margin. Virtual intratumoral surgical section was speculated in 44 patients (3 developed anastomotic recurrence; 6.8 vs 4.8 %, p = 0.482). CONCLUSION: Anastomotic recurrence in patients with rectal cancer treated with neoadjuvant chemoradiation is an infrequent event. Virtual intratumoral surgical sections followed by anastomosis do not contribute to an excessive risk of recurrence. Our findings encourage the development of policies for preservation of the ano-rectal complex in rectal cancer patients (AU)


No disponible


Subject(s)
Humans , Male , Female , Rectal Neoplasms/drug therapy , Rectal Neoplasms/radiotherapy , Rectal Neoplasms/surgery , Rectal Neoplasms/diagnosis , Rectal Neoplasms/secondary , Anal Canal/abnormalities , Chemoradiotherapy
8.
Plant Biol (Stuttg) ; 16(3): 528-38, 2014 May.
Article in English | MEDLINE | ID: mdl-24433330

ABSTRACT

Space experiments provide a unique opportunity to advance our knowledge of how plants respond to the space environment, and specifically to the absence of gravity. The European Modular Cultivation System (EMCS) has been designed as a dedicated facility to improve and standardise plant growth in the International Space Station (ISS). The EMCS is equipped with two centrifuges to perform experiments in microgravity and with variable gravity levels up to 2.0 g. Seven experiments have been performed since the EMCS was operational on the ISS. The objectives of these experiments aimed to elucidate phototropic responses (experiments TROPI-1 and -2), root gravitropic sensing (GRAVI-1), circumnutation (MULTIGEN-1), cell wall dynamics and gravity resistance (Cell wall/Resist wall), proteomic identification of signalling players (GENARA-A) and mechanism of InsP3 signalling (Plant signalling). The role of light in cell proliferation and plant development in the absence of gravity is being analysed in an on-going experiment (Seedling growth). Based on the lessons learned from the acquired experience, three preselected ISS experiments have been merged and implemented as a single project (Plant development) to study early phases of seedling development. A Topical Team initiated by European Space Agency (ESA), involving experienced scientists on Arabidopsis space research experiments, aims at establishing a coordinated, long-term scientific strategy to understand the role of gravity in Arabidopsis growth and development using already existing or planned new hardware.


Subject(s)
Plant Development , Spacecraft , Arabidopsis/physiology , Equipment Design , Europe
9.
Clin Transl Oncol ; 16(6): 573-80, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24129427

ABSTRACT

BACKGROUND AND PURPOSE: Anastomotic recurrence after radical sphincter-preserving surgery preceded by neoadjuvant therapy in locally advanced rectal cancer is an uncommon event that merits further assessment. The aim of this study is to analyze the effect of preoperative chemoradiation on the risk of anastomotic recurrence. Based on the initial extension of the tumor, we analyzed whether the distal surgical section was calculated through the virtual initial extension of the rectal tumor. PATIENTS AND METHODS: Eligible patients with locally advanced rectal cancer were offered preoperative chemoradiation, sphincter sparing surgery and intraoperative radiation therapy boost. RESULTS: 180 patients were treated with anterior resection (40 %), low anterior resection (45.6 %) and ultra-low anterior resection (14.4 %). With a median follow-up of 41.1 months (0.36-143 months), anastomotic recurrence was diagnosed in 9 patients (5 %). There was no statistical correlation with downstaging (T or N), downsizing effects, or with distance from the lower limit of the residual lesion to the distal margin. Virtual intratumoral surgical section was speculated in 44 patients (3 developed anastomotic recurrence; 6.8 vs 4.8 %, p = 0.482). CONCLUSION: Anastomotic recurrence in patients with rectal cancer treated with neoadjuvant chemoradiation is an infrequent event. Virtual intratumoral surgical sections followed by anastomosis do not contribute to an excessive risk of recurrence. Our findings encourage the development of policies for preservation of the ano-rectal complex in rectal cancer patients.


Subject(s)
Adenocarcinoma/therapy , Anastomosis, Surgical/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemoradiotherapy , Neoplasm Recurrence, Local/diagnosis , Rectal Neoplasms/therapy , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoadjuvant Therapy , Neoplasm Recurrence, Local/etiology , Neoplasm Staging , Organ Sparing Treatments , Preoperative Care , Prognosis , Rectal Neoplasms/pathology , Risk Factors
11.
Plant Biol (Stuttg) ; 16 Suppl 1: 23-30, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24112664

ABSTRACT

Gravity is a key factor for life on Earth. It is the only environmental factor that has remained constant throughout evolution, and plants use it to modulate important physiological activities; gravity removal or alteration produces substantial changes in essential functions. For root gravitropism, gravity is sensed in specialised cells, which are capable of detecting magnitudes of the g vector lower than 10(-3) . Then, the mechanosignal is transduced to upper zones of the root, resulting in changes in the lateral distribution of auxin and in the rate of auxin polar transport. Gravity alteration has consequences for cell growth and proliferation rates in root meristems, which are the basis of the developmental programme of a plant, in which regulation via auxin is involved. The effect is disruption of meristematic competence, i.e. the strict coordination between cell proliferation and growth, which characterises meristematic cells. This effect can be related to changes in the transport and distribution of auxin throughout the root. However, similar effects of gravity alteration have been found in plant cell cultures in vitro, in which neither specialised structures for gravity sensing and signal transduction, nor apparent gravitropism have been described. We postulate that gravity resistance, a general mechanism of cellular origin for developing rigid structures in plants capable of resisting the gravity force, could also be responsible for the changes in cell growth and proliferation parameters detected in non-specialised cells. The mechanisms of gravitropism and graviresistance are complementary, the first being mostly sensitive to the direction of the gravity vector, and the second to its magnitude. At a global molecular level, the consequence of gravity alteration is that the genome should be finely tuned to counteract a type of stress that plants have never encountered before throughout evolution. Multigene families and redundant genes present an advantage in that they can experience changes without the risk of being deleterious and, for this reason, they should play a key role in the response to gravitational stress.


Subject(s)
Environment , Gravity, Altered , Plant Development , Biological Evolution , Cell Proliferation , Gravitropism
12.
Ecancermedicalscience ; 7: 339, 2013.
Article in English | MEDLINE | ID: mdl-24009641

ABSTRACT

RATIONALE AND OBJECTIVES: To analyse the programme activity and clinical innovation and/or technology developed over a period of 17 years with regard to the introduction and the use of intraoperative radiotherapy (IORT) as a therapeutic component in a medical-surgical multidisciplinary cancer hospital. MATERIAL AND METHODS: To standardise and record this procedure, the Radiation Oncology service has an institutional programme and protocols that must be completed by the different specialists involved. For 17 years, IORT procedures were recorded on a specific database that includes 23 variables with information recorded on institutional protocols. As part of the development and innovation activity, two technological tools were implemented (RADIANCE and MEDTING) in line with the standardisation of this modality in clinical practice. RESULTS: During the 17 years studied, 1,004 patients were treated through 1,036 IORT procedures. The state of the disease at the time of IORT was 77% primary and 23% recurrent. The origin and distribution of cancers were 62% gastrointestinal, 18% sarcomas, 5% pancreatic, 2% paediatric, 3% breast, 7% less common locations, and 2% others. The research and development projects have generated a patent on virtual planning (RADIANCE) and proof of concept to explore as a professional social network (MEDTING). During 2012, there were 69 IORT procedures. There was defined treatment volume (target or target region) in all of them, and 43 were conducted by the virtual planning RADIANCE system. Eighteen have been registered on the platform MEDTING as clinical cases. CONCLUSION: The IORT programme, developed in a university hospital with an academic tradition, and interdisciplinary surgical oncology, is a feasible care initiative, able to generate the necessary intense clinical activity for tending to the cancer patient. Moreover, it is a competitive source for research, development, and scientific innovation.

13.
Clin. transl. oncol. (Print) ; 15(9): 683-690, sept. 2013. ilus
Article in English | IBECS | ID: ibc-127486

ABSTRACT

The reality of intraoperative radiation therapy (IORT) practice is consistent with an efficient and highly precise radiation therapy technique to safely boost areas at risk for local recurrence. Long-term clinical experience has shown that IORT-containing multi-modality regimens appear to improve local disease control, if not survival in many diseases. Research with IORT is a multidisciplinary scenario that covers knowledge from radiation beam adapted development to advance molecular biology for bio-predictability of outcome. The technical parameters employed in IORT procedures are important information to be recorded for quality assurance and clinical results analysis. In addition, specific treatment planning systems for IORT procedures are available, to help in the treatment decision-making process. A systematic revision of opportunities for research and innovation in IORT is reported including radiation beam modulation, delivery, dosimetry and planning; infrastructure and treatment factors; experimental and clinical radiobiology; clinical trials, innovation and translational research development (AU)


Subject(s)
Humans , Male , Female , Chemotherapy, Adjuvant/classification , Chemotherapy, Adjuvant/methods , Chemotherapy, Adjuvant , Research Support as Topic/methods , Survivorship/psychology
14.
Clin Transl Oncol ; 15(9): 683-90, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23463592

ABSTRACT

The reality of intraoperative radiation therapy (IORT) practice is consistent with an efficient and highly precise radiation therapy technique to safely boost areas at risk for local recurrence. Long-term clinical experience has shown that IORT-containing multi-modality regimens appear to improve local disease control, if not survival in many diseases. Research with IORT is a multidisciplinary scenario that covers knowledge from radiation beam adapted development to advance molecular biology for bio-predictability of outcome. The technical parameters employed in IORT procedures are important information to be recorded for quality assurance and clinical results analysis. In addition, specific treatment planning systems for IORT procedures are available, to help in the treatment decision-making process. A systematic revision of opportunities for research and innovation in IORT is reported including radiation beam modulation, delivery, dosimetry and planning; infrastructure and treatment factors; experimental and clinical radiobiology; clinical trials, innovation and translational research development.


Subject(s)
Neoplasms/radiotherapy , Neoplasms/surgery , Clinical Trials as Topic , Combined Modality Therapy/methods , Humans , Intraoperative Period , Neoplasm Recurrence, Local/radiotherapy , Neoplasm Recurrence, Local/surgery , Radiometry/methods , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Adjuvant , Translational Research, Biomedical/methods , Treatment Outcome
15.
Eur J Neurol ; 20(5): 795-802, 2013 May.
Article in English | MEDLINE | ID: mdl-23278976

ABSTRACT

BACKGROUND AND PURPOSE: Perfusion-computed tomography-source images (PCT-SI) may allow a dynamic assessment of leptomeningeal collateral arteries (LMC) filling and emptying in middle cerebral artery (MCA) ischaemic stroke. We described a regional LMC scale on PCT-SI and hypothesized that a higher collateral score would predict a better response to intravenous (iv) thrombolysis. METHODS: We studied consecutive ischaemic stroke patients with an acute MCA occlusion documented by transcranial Doppler/transcranial color-coded duplex, treated with iv thrombolysis who underwent PCT prior to treatment. Readers evaluated PCT-SI in a blinded fashion to assess LMC within the hypoperfused MCA territory. LMC scored as follows: 0, absence of vessels; 1, collateral supply filling ≤ 50%; 2, between> 50% and < 100%; 3, equal or more prominent when compared with the unaffected hemisphere. The scale was divided into good (scores 2-3) vs. poor (scores 0-1) collaterals. The predetermined primary end-point was a good 3-month functional outcome, while early neurological recovery, transcranial duplex-assessed 24-h MCA recanalization, 24-h hypodensity volume and hemorrhagic transformation were considered secondary end-points. RESULTS: Fifty-four patients were included (55.5% women, median NIHSS 10), and 4-13-23-14 patients had LMC score (LMCs) of 0-1-2-3, respectively. The probability of a good long-term outcome augmented gradually with increasing LMCs: (0) 0%; (1) 15.4%; (2) 65.2%; (3) 64.3%, P = 0.004. Good-LMCs was independently associated with a good outcome [OR 21.02 (95% CI 2.23-197.75), P = 0.008]. Patients with good LMCs had better early neurological recovery (P = 0.001), smaller hypodensity volumes (P < 0.001) and a clear trend towards a higher recanalization rate. CONCLUSIONS: A higher degree of LMC assessed by PCT-SI predicts good response to iv thrombolysis in MCA ischaemic stroke patients.


Subject(s)
Cerebrovascular Circulation/physiology , Collateral Circulation/physiology , Fibrinolytic Agents/therapeutic use , Infarction, Middle Cerebral Artery/physiopathology , Perfusion Imaging , Tissue Plasminogen Activator/therapeutic use , Administration, Intravenous , Aged , Cerebrovascular Circulation/drug effects , Female , Fibrinolytic Agents/administration & dosage , Humans , Infarction, Middle Cerebral Artery/diagnostic imaging , Infarction, Middle Cerebral Artery/drug therapy , Male , Prospective Studies , Tissue Plasminogen Activator/administration & dosage , Ultrasonography
16.
Radiat Prot Dosimetry ; 151(4): 621-5, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22923244

ABSTRACT

In Europe, a network for biological dosimetry has been created to strengthen the emergency preparedness and response capabilities in case of a large-scale nuclear accident or radiological emergency. Through the RENEB (Realising the European Network of Biodosimetry) project, 23 experienced laboratories from 16 European countries will establish a sustainable network for rapid, comprehensive and standardised biodosimetry provision that would be urgently required in an emergency situation on European ground. The foundation of the network is formed by five main pillars: (1) the ad hoc operational basis, (2) a basis of future developments, (3) an effective quality-management system, (4) arrangements to guarantee long-term sustainability and (5) awareness of the existence of RENEB. RENEB will thus provide a mechanism for quick, efficient and reliable support within the European radiation emergency management. The scientific basis of RENEB will concurrently contribute to increased safety in the field of radiation protection.


Subject(s)
Radiation Protection , Radioactive Hazard Release , Civil Defense , Emergencies , Europe , Humans , Radioactive Hazard Release/prevention & control
17.
Rev. neurol. (Ed. impr.) ; 54(7): 415-419, 1 abr., 2012. tab, graf
Article in Spanish | IBECS | ID: ibc-99567

ABSTRACT

Introducción. El 30% de los pacientes con esclerosis múltiple (EM) presenta respuesta subóptima al tratamiento en los primeros años. El impacto real del cambio de tratamiento no está bien establecido. Objetivos. Describir nuestra práctica clínica sobre el cambio de tratamiento en los pacientes con EM con respuesta subóptima y analizar la evolución en función de nuestras decisiones terapéuticas. Pacientes y métodos. Estudio observacional y retrospectivo. Se incluyeron pacientes con EM remitente recurrente con al menos un brote después de instaurado el tratamiento inmunomodulador. Se tuvieron en cuenta la intención de cambio de tratamiento y los retrasos hasta el momento real del cambio. Las consecuencias teóricas de estas estrategias se midieron por los cambios en la curva esperada de la Multiple Sclerosis Severity Scale (MSSS). Resultados. Los pacientes que cambiaron de inmunomodulador mejoraron la curva esperada de la MSSS (p > 0,05) respecto a los que no (64,3% frente a 35,3%). Los pacientes que mejoraron esa curva habían cambiado de tratamiento antes que los que no mejoraron (1,9 meses frente a 6 meses), aunque las diferencias no fueron significativas. El tiempo transcurrido entre el planteamiento y el cambio real de tratamiento tuvo una media de 2,70 ± 3,55 meses. Conclusiones. A pesar de las limitaciones por el tamaño de la muestra, los pacientes con respuesta subóptima que cambian de tratamiento precozmente podrían beneficiarse de una mejoría en su evolución esperada por la MSSS (AU)


Introduction. Thirty per cent of patients with multiple sclerosis (MS) present a suboptimal response to treatment in the first few years. The real impact of the change of treatment has still not been well established. Aims. To describe our clinical practice with regard to the change of treatment in MS patients with a suboptimal response and to analyse their progress depending on our therapeutic decisions. Patients and methods. The study is observation-based and retrospective. The sample was made up of patients with relapsingremitting MS and at least one event after establishing immunomodulatory treatment. Both the intention to change treatment and the delays until the actual change took place were taken into account. The theoretical consequences of these strategies were measured by the changes in the expected curve of the Multiple Sclerosis Severity Scale (MSSS). Results. A comparison of those who changed immunomodulator with those that did not showed that 64.3% versus 35.3%, respectively, improved on the expected curve of the MSSS (p > 0.05). Patients who improved the expected curve of the MSSS had changed treatment before those who did not improve (1.9 months versus 6 months), although the differences were not significant. The mean time that elapsed between taking the decision to change and actually changing the treatment was 2.70 ± 3.55 months. Conclusions. Despite limitations due to the size of the sample, the patients with a suboptimal response who changed treatment early could benefit from an improvement in their expected progression on the MSSS (AU)


Subject(s)
Humans , Multiple Sclerosis/drug therapy , Immunologic Factors/therapeutic use , Severity of Illness Index , Treatment Outcome , Retrospective Studies
18.
Rev Neurol ; 54(7): 415-9, 2012 Apr 01.
Article in Spanish | MEDLINE | ID: mdl-22451128

ABSTRACT

INTRODUCTION: Thirty per cent of patients with multiple sclerosis (MS) present a suboptimal response to treatment in the first few years. The real impact of the change of treatment has still not been well established. AIMS: To describe our clinical practice with regard to the change of treatment in MS patients with a suboptimal response and to analyse their progress depending on our therapeutic decisions. PATIENTS AND METHODS: The study is observation-based and retrospective. The sample was made up of patients with relapsing-remitting MS and at least one event after establishing immunomodulatory treatment. Both the intention to change treatment and the delays until the actual change took place were taken into account. The theoretical consequences of these strategies were measured by the changes in the expected curve of the Multiple Sclerosis Severity Scale (MSSS). RESULTS: A comparison of those who changed immunomodulator with those that did not showed that 64.3% versus 35.3%, respectively, improved on the expected curve of the MSSS (p > 0.05). Patients who improved the expected curve of the MSSS had changed treatment before those who did not improve (1.9 months versus 6 months), although the differences were not significant. The mean time that elapsed between taking the decision to change and actually changing the treatment was 2.70 ± 3.55 months. CONCLUSIONS: Despite limitations due to the size of the sample, the patients with a suboptimal response who changed treatment early could benefit from an improvement in their expected progression on the MSSS.


Subject(s)
Antirheumatic Agents/therapeutic use , Disease Management , Immunologic Factors/therapeutic use , Multiple Sclerosis, Relapsing-Remitting/drug therapy , Adult , Antirheumatic Agents/administration & dosage , Confounding Factors, Epidemiologic , Female , Glatiramer Acetate , Humans , Immunologic Factors/administration & dosage , Interferon beta-1b , Interferon-beta/administration & dosage , Interferon-beta/therapeutic use , Male , Multiple Sclerosis, Relapsing-Remitting/therapy , Peptides/administration & dosage , Peptides/therapeutic use , Retrospective Studies , Sample Size , Severity of Illness Index , Treatment Outcome
19.
Adv Space Res ; 40(4): 506-512, 2007 Apr.
Article in English | MEDLINE | ID: mdl-18084631

ABSTRACT

The European Soyuz missions have been one of the main routes for conducting scientific experiments onboard the International Space Station, which is currently in the construction phase. A relatively large number of life and physical sciences experiments as well as technology demonstrations have been carried out during these missions. Included among these experiments are the Gene experiment during the Spanish "Cervantes" Soyuz mission and the ICE-1st experiment during the Dutch "Delta" mission. In both experiments, full genome microarray analyses were carried out on RNA extracted from whole animals recovered from the flight. These experiments indicated relatively large scale changes in gene expression levels in response to spaceflight for two popular model systems, Drosophila melanogaster (Gene) and Caenorabditis elegans (ICE-1st). Here we report a comparative analysis of results from these two experiments. Finding orthologous genes between the fruit fly and the nematode was far from straightforward, reducing the number of genes that we could compare to roughly 20% of the full comparative genome. Within this sub-set of the data (2286 genes), only six genes were found to display identical changes between species (decreased) while 1809 genes displayed no change in either species. Future experiments using ground simulation techniques will allow producing a better, more comprehensive picture of the putative set of genes affected in multicellular organisms by changes in gravity and getting a deeper understanding of how animals respond and adapt to spaceflight.

20.
Arch Soc Esp Oftalmol ; 80(9): 547-9, 2005 Sep.
Article in Spanish | MEDLINE | ID: mdl-16193440

ABSTRACT

CASE REPORT: A female patient underwent laser in situ keratomileusis (LASIK) in both eyes. The final degree of astigmatism in her left eye was double the preoperative value due to an error in data management. Complex surgery to both eyes was necessary to resolve the mistake. DISCUSSION: Complications in refractive surgery can occur, however errors in data management must be minimized by double-checking. Solutions to resolve the errors made can be difficult and the entire staff must share responsibility to avoid these undesirable outcomes.


Subject(s)
Astigmatism/surgery , Keratomileusis, Laser In Situ/adverse effects , Medical Errors , Corneal Topography , Female , Follow-Up Studies , Humans , Middle Aged , Postoperative Complications , Reoperation , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...